SIONNA THERAPEUTICS, INC. Shares Outstanding (Cover Page)
SIONNA THERAPEUTICS, INC. (SION) had Shares Outstanding (Cover Page) of 45.21 million shares as of 2026-07-31, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-06
- 2026-07-31: Entity Common Stock, Shares Outstanding 45.21M shares.
- 2026-04-30: Entity Common Stock, Shares Outstanding 45.15M shares.
- 2026-02-20: Entity Common Stock, Shares Outstanding 45.00M shares.
- 2025-10-31: Entity Common Stock, Shares Outstanding 44.63M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-07-31 | 45.21M shares 10-Q · filed 2026-08-06 |
| 2026-04-30 | 45.15M shares 10-Q · filed 2026-05-12 |
| 2026-02-20 | 45.00M shares 10-K · filed 2026-03-02 |
| 2025-10-31 | 44.63M shares 10-Q · filed 2025-11-05 |
| 2025-08-01 | 44.14M shares 10-Q · filed 2025-08-11 |
| 2025-05-01 | 44.12M shares 10-Q · filed 2025-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| Lyell Immunopharma, Inc. (LYEL) | United States | $0.248B | -1.32 |